Mercado Charles P, Kilic Fusun
Department of Biochemistry and Molecular Biology College of Medicine, The University of Arkansas for Medical Sciences Little Rock, Arkansas 72205, USA.
Mol Interv. 2010 Aug;10(4):231-41. doi: 10.1124/mi.10.4.6.
The serotonin transporter (SERT) on platelets is a primary mechanism for serotonin (5HT) uptake from the blood plasma. Alteration in plasma 5HT level is associated with a number of cardiovascular diseases and disorders. Therefore, the regulation of the transporter's activity represents a key mechanism to stabilize the concentration of plasma 5HT. There is a biphasic relationship between plasma 5HT elevation, loss of surface SERT, and depletion of platelet 5HT. Specifically, in platelets, plasma membrane SERT levels and platelet 5HT uptake initially rise as plasma 5HT levels are increased but then fall below normal as the plasma 5HT level continues to rise. Therefore, we propose that elevated plasma 5HT limits its own uptake in platelets by down-regulating SERT as well as modifying the characteristics of SERT partners in the membrane trafficking pathway. This review will summarize current findings regarding the biochemical mechanisms by which elevated 5HT downregulates the expression of SERT on the platelet membrane. Intriguing aspects of this regulation include the intracellular interplay of SERT with the small G protein Rab4 and the concerted 5HT-mediated phosphorylation of vimentin.
血小板上的5-羟色胺转运体(SERT)是从血浆中摄取5-羟色胺(5HT)的主要机制。血浆5HT水平的改变与多种心血管疾病和病症相关。因此,转运体活性的调节是稳定血浆5HT浓度的关键机制。血浆5HT升高、表面SERT丧失和血小板5HT耗竭之间存在双相关系。具体而言,在血小板中,随着血浆5HT水平升高,质膜SERT水平和血小板5HT摄取最初会上升,但随着血浆5HT水平持续升高,随后会降至正常水平以下。因此,我们提出血浆5HT升高通过下调SERT以及改变膜转运途径中SERT伙伴的特性来限制其自身在血小板中的摄取。本综述将总结有关5HT升高下调血小板膜上SERT表达的生化机制的当前研究结果。这种调节的有趣方面包括SERT与小G蛋白Rab4的细胞内相互作用以及5HT介导的波形蛋白协同磷酸化。